Rationale
for Proposed National Surgical Adjuvant Breast and Bowel Project
(NSABP) DCIS Trial
Tamoxifen versus Arimidex® (anastrozole) in Postmenopausal
Patients with Ductal Carcinome in Situ
Richard Margolese, MD
2000
NIH Consensus Conference on Adjuvant Therapy of Breast Cancer
Richard Kaderman, Ph.D.
Recent
Changes in Physicians' Interpretation of Estrogen Receptor (ER)
Assay Results: Adjuvant Endocrine Therapy in Patients with low,
but Detectable ER
Jennifer Motley, MD
Post-Radiation
Angio Sarcoma of the Breast
Gal-Combos EC, Esserman LE, Godinez J, Recine MA and Poppiti RJ,
Jr.
Management
of BI-RADS Category 5 Lesions: Usefulness of Fine-Needle Aspiration
Gal-Gombos EC, Esserman LE, Welsberry S, Recine MA and Poppifi
RJ, Jr.
Rationale
for Proposed NSABP Adjuvant Trial (B-35)
A Randomized Trial Comparing 5 Years of Faslodex® (fulvestrant)
to 5 years of Tamoxifen in Women with Hormone Receptor - Positive,
Node-negative Breast Cancer
Richard Elledge, MD
A
Decade of Sentinel Lymph Node Mapping in Breast Cancer:
A Hypothesis - Driven Journey Toward a New Paradign
Grube BJ, Hansen NM, Turner RR, Brennan MB, Krasne DL, Glass EC,
Giuliano AE
The
UK Almanac Trial (MRC) - Early Results
Professor RE Mansel-Principal Investigator on behalf of the ALMANAC
Trialists Group
Factors
Influencing Surgical Choices in Women with Breast Cancer
Valerie L. Staradub, MD, Yi-Ching Haleh, MS, Jennifer Clauson
BS, Alexander Langerman, BA, Alfred W. Rademaker, Ph.D., Monica
Morrow, MD
Reduction
Mammoplasty to Improve Breast Conservation Therapy Results in
Patients with Macromastia
Newman, Lisa A; Kuerer, Henry Mark; Gurtner, Joseph; Ames, Fred
C; Ross, Merick I; McNeese, Marsha D; Robb, Geoffery; Singletary,
S Eva
Current
NSABP Breast Cancer Trials
Richard Kaderman, Ph.D.
The
Intradermal Sentinel Node: Update 2000
Owen DH
Ductal
Lavage and Detection of Abnormal Cytology in Women at High Risk
for Breast Cancer
William Dooley, Umberto Veronesi, Richard Elledge, Joyce O'Shaughnessy,
Susan Love, Britt Marie Ljung and the Ductal Lavage Investigators
Evaluation
of Local and Systemic Disease Control Following Breast Conserving
Surgery After Neoadjuvant Anastrozole Treatment
Sahni S, Daltrey I, Renshaw L, Miller WR, Dixon JM
Breast
Cancer Risk Assesment in the Primary Care Setting: A Pilot Teleconference
/ E-mail Program Targeting Gynecologists, Nurse Practitioners
and Physicians Assistants
Sally Bogert, NP; Michelle Finklestein, MD; Elena Cyrus, BA; Jennifer
Motley, MD; Neil Love, MD
